All Stories

  1. The farnesoid X receptor agonist EDP-305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction

    Article • The FASEB Journal, March 2019, Federation of American Societies For Experimental Biology (FASEB)

    Kenneth Tanabe, Lijuan Jiang, Gunisha Arora

  2. Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonist

    Article • Hepatology Communications, May 2018, Wiley

    Lijuan Jiang